TAP
51
-2
LYB
44
-2
FMC
36
3
EXC
50
-4
PBI
62
2
TJX
50
2
PM
52
-4
HRB
70
-3
BLK
69
2
NFLX
55
-3
AIZ
71
-2
MAR
50
3
MS
50
-8
NSC
62
2
AMGN
55
-2
AVY
54
-14
BF.B
57
7
DLTR
31
3
SYY
50
-8
ES
55
-5
TAP
51
-2
LYB
44
-2
FMC
36
3
EXC
50
-4
PBI
62
2
TJX
50
2
PM
52
-4
HRB
70
-3
BLK
69
2
NFLX
55
-3
AIZ
71
-2
MAR
50
3
MS
50
-8
NSC
62
2
AMGN
55
-2
AVY
54
-14
BF.B
57
7
DLTR
31
3
SYY
50
-8
ES
55
-5
Financhill
Back

GitLab Vs. Avidity Biosciences Industry Stock Comparison

Buy
69

GTLB
GitLab

Last Price:
52.32
Seasonality Move:
7.24%
Sell
31

RNA
Avidity Biosciences

Last Price:
45.67
Seasonality Move:
-1.3%
Buy
69
GitLab (GTLB) is a Buy

Is GitLab a Buy, Sell or Hold?

  • The current GitLab [GTLB] share price is $52.35. The Score for GTLB is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • GTLB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

  • The current Avidity Biosciences [RNA] share price is $45.68. The Score for RNA is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GTLB Stock Price Chart

What is GitLab's stock price today?

  • The GitLab share price today is $52.35
    The current trend is moderately bullish and GTLB is experiencing selling pressure, which indicates risk of future bearish movement.

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

  • The Avidity Biosciences share price today is $45.68
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing slight buying pressure.

GTLB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.42 Buy
Relative Strength Index (14 RSI): 54.23 Buy
Chaikin Money Flow: -1312196 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.09 - 53.81) Buy
Bollinger Bands (100): (45.31 - 54.57) Buy

RNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 62 Buy
Chaikin Money Flow: 402350 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.19 - 44.69) Buy
Bollinger Bands (100): (30.3 - 45.36) Buy

GTLB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.5 Sell
20-day SMA: 50.92 Buy
50-day SMA: 49.42 Buy
200-day SMA: 56.4 Sell
8-day EMA: 52.52 Sell
20-day EMA: 51.3 Buy
50-day EMA: 50.05 Buy
200-day EMA: 52.06 Buy

RNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.33 Buy
20-day SMA: 42.39 Buy
50-day SMA: 43.82 Buy
200-day SMA: 26.96 Buy
8-day EMA: 43.04 Buy
20-day EMA: 42.7 Buy
50-day EMA: 41.84 Buy
200-day EMA: 30.49 Buy

GitLab Earnings Growth & GTLB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.02 per share, an increase this year of $0.70 per share, and an increase next year of $0.34 per share.

Avidity Biosciences Earnings Growth & RNA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.20 per share, and a decrease next year of $0.17 per share.

GitLab Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Avidity Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):